Thinning Pipelines by MARIE DAGHLIAN Burrill Biotech Report Pharma companies push away the plate on diet pills as concern grows over a risk averse regulatory environment.
Searching For A Bottom A wild week on Wall Street may change the financial landscape for years to come.
I Want A New Drug by DANIEL S. LEVINE IDIS Pharmaceuticals has carved out a niche by connecting patients to drugs not yet approved in their countries. Now it's taking its services to the United States.
Billion Dollar Copycats Generic drugmakers tout billions in savings that could be realized with the introduction of biogenerics.
Thinking Small by LORI ANDREWS AND JULIE BURGER U.S. patent officials and other regulators must get up to speed on the intricacies of tiny particles to avoid hindering the growth of nanotechnology.
Untethering Innovation by BRADFORD PLUMER One year before a new president takes office, Congress lies low, but bills on patents, biologics, genetics, and a host of other issues could still affect R&D.
Playing It Safe The U.S. Food and Drug Administration opens three offices in China.
A Reform Agenda by Daniel S. Levine Obama Taps Tom Daschle To Head HHS.
Going Dutch The United States is a leader in patient-reported medical errors, wasteful or poorly coordinated care, and high out-of-pocket costs. The Dutch often fare best.
Finding When The Worm Has Turned Research in nematodes could lead to tests that provide an objective means of evaluating anti-aging therapeutics ability to delay aging.
Young At Brain Elderly people with unusually sharp memory provide insight into what happens to people suffering from Alzheimer’s disease.
Getting Protection by DANIEL S. LEVINE San Diego biotech' results show DNA vaccine could work in humans.
Political Scientists by DANIEL S. LEVINE As Washington gets ready to overhaul the healthcare system, research advocates want to make sure innovation doesn't take a backseat to the bottom line.
Wheeled Away by ERIC WAHLGREN Golf cart injuries surge along with the vehicles' use on and off the links.